Acadia Healthcare (NASDAQ:ACHC) Shares Down 20.5% - Here's What Happened

Key Points

• Shares plunged 20.5% to about $22.45 on Thursday, marking a sharp sell-off despite relatively light intraday volume versus the stock's average.
• Although Acadia beat Q1 estimates (EPS $0.37 vs. $0.28; revenue $828.8M, +7.6% YoY), the stock fell after management issued Q2 guidance below street expectations (EPS $0.30–$0.40 vs. ~ $0.46 and revenue $835–$850M vs. ~ $867M) and named an interim CFO, raising execution and leadership concerns.
• Market reaction is mixed: there is unusual bullish call-option activity and interest from value managers that could support demand, while analysts maintain a consensus "Hold" rating with an average price target of about $23.04.

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) dropped 20.5% on Thursday . The stock traded as low as $24.25 and last traded at $22.4550. Approximately 711,208 shares were traded during trading, a decline of 80% from the average daily volume of 3,474,513 shares. The stock had previously closed at $28.26.

More Acadia Healthcare News

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Q1 results beat expectations — EPS $0.37 vs. consensus $0.28 and revenue $828.8M (+7.6% YoY). Strong same-facility revenue drivers (higher revenue per patient day and modest patient-day growth) show underlying demand. Acadia Healthcare (ACHC) Q1 Earnings and Revenues Beat Estimates
• Positive Sentiment: Unusually large call-option activity — traders bought ~3,427 calls (about 112% above average), indicating speculative bullish positioning that can amplify upside on any confirming news.
• Positive Sentiment: Investor interest from notable value managers is being highlighted (Acadia appears on lists of under-the-radar picks), which can support longer-term demand. 5 Under-the-Radar Picks from David Einhorn
• Neutral Sentiment: Company released full press release, slide deck and hosted a conference call — useful for modeling patient-mix, pricing trends and M&A commentary but not immediately directional without further detail. Acadia Healthcare Announces First Quarter 2026 Results
• Negative Sentiment: Q2 guidance came in below consensus — EPS guide $0.30–$0.40 vs. Street ~$0.46 and revenue guide $835–$850M vs. ~$867M consensus. This guidance shortfall is the primary near-term negative catalyst pressuring the stock.
• Negative Sentiment: Interim CFO appointment raises leadership/stability questions and could create investor uncertainty around execution and financial cadence. Interim CFO Appointment Tests Acadia Healthcare Leadership Stability And 2026 Targets
• Negative Sentiment: Market reaction: despite the quarterly beat, headlines note the stock dropped on the guidance/leadership concerns — this reflects the market focusing on forward guidance and execution risk. Acadia Healthcare NASDAQ: ACHC Surprises With Q1 CY2026 Sales But Stock Drops

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Guggenheim lowered their target price on Acadia Healthcare from $27.00 to $22.00 and set a "buy" rating on the stock in a report on Monday, February 23rd. Jefferies Financial Group reaffirmed a "hold" rating and set a $24.50 target price on shares of Acadia Healthcare in a report on Monday, April 20th. UBS Group lifted their target price on Acadia Healthcare from $27.00 to $31.00 and gave the stock a "buy" rating in a report on Friday, April 17th. Finally, Raymond James Financial reaffirmed an "outperform" rating and set a $25.00 target price on shares of Acadia Healthcare in a report on Thursday, February 26th. Seven investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $23.04.

Acadia Healthcare Price Performance

The stock has a market capitalization of $2.13 billion, a price-to-earnings ratio of -1.88, a price-to-earnings-growth ratio of 9.51 and a beta of 0.71. The company has a current ratio of 1.55, a quick ratio of 1.55 and a debt-to-equity ratio of 1.27. The stock has a 50-day simple moving average of $24.25 and a 200 day simple moving average of $19.15.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping analysts' consensus estimates of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The firm had revenue of $828.80 million during the quarter, compared to analyst estimates of $822.89 million. During the same period last year, the company posted $0.40 EPS. The business's quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 1.48 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in ACHC. Principal Financial Group Inc. grew its holdings in Acadia Healthcare by 112.1% in the 3rd quarter. Principal Financial Group Inc. now owns 442,943 shares of the company's stock valued at $10,967,000 after buying an additional 234,107 shares during the last quarter. Invenomic Capital Management LP grew its holdings in Acadia Healthcare by 41.6% in the 3rd quarter. Invenomic Capital Management LP now owns 1,936,396 shares of the company's stock valued at $47,945,000 after buying an additional 568,796 shares during the last quarter. Vanguard Group Inc. grew its holdings in Acadia Healthcare by 7.8% in the 3rd quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company's stock valued at $233,166,000 after buying an additional 681,278 shares during the last quarter. First Citizens Bank & Trust Co. grew its holdings in Acadia Healthcare by 164.1% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 59,123 shares of the company's stock valued at $1,464,000 after buying an additional 36,733 shares during the last quarter. Finally, Public Sector Pension Investment Board acquired a new stake in Acadia Healthcare in the 3rd quarter valued at approximately $8,919,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.